Target Identification

Target Validation

Hit Identification

Hit-to-Lead

Lead Optimization

Pre-Clinical Studies

Clinical Development

INCUBATION PROJECTS
MATURATION PROJECTS
  • Novel MLL-AF9 AML biomarkers & Antibodies
  • Pharmacological Chaperones *
  • Drug repositioning in AML
  • Undisclosed Project 5
  • Undisclosed Project 6
  • Undisclosed Project 4
  • Hematopoietic stem cell expanding molecule: Compound 2
  • Hematopoietic stem cell expanding molecule: Compound 1
  • Undisclosed Project 7
  • Ribavirin in Leukemia
  • Immunotherapy in Leukemia

For more information,
View this document

 
Enabling Drug Discovery Tools
  • CRISPR/Cas9 chemogenomic profiling
  • BRET Biosensor Program
  • Cyclic peptidomimetics
  • Proprietary Small Molecules (IRIC’s collection)
  • SUMOylation Detection Method *

Legend

  *    Project for potential partnership
  IRICoR investment at later stage (Maturation Project Committee)
  IRICoR investment at early stage (Incubation Project Committee)
  IRICoR investment at both early and late stages of development

Last update: 2018-03-05